Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report

Publisher： Karger

E-ISSN： 1421-9751|137|2|74-77

ISSN： 0008-6312

Source： Cardiology, Vol.137, Iss.2, 2017-02, pp. : 74-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tafamidis delays neurological progression comparably across Val30Met and non‐Val30Met genotypes in transthyretin familial amyloid polyneuropathy

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 3, 2018-03 ,pp. : 464-468

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

By  

Oncology, Vol. 90, Iss. 3, 2016-02 ,pp. : 176-177

Karger

Access to resources Recommend Favorite

Orthodontic treatment for a patient with hereditary angiodema: a case report

By  

INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, Vol. 25, Iss. 3, 2015-05 ,pp. : 229-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

By Coelho Teresa   Maurer Mathew S.   Suhr Ole B.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 63-76

Informa Healthcare

Access to resources Recommend Favorite

Cardiomyopathy Related to Antimalarial Therapy with Illustrative Case Report

By  

Cardiology, Vol. 107, Iss. 2, 2006-06 ,pp. : 73-80

Karger

Access to resources Recommend Favorite